Department of Medicine, Aga Khan University, Stadium Road, Karachi, 74800, Pakistan.
BMC Gastroenterol. 2013 Feb 21;13:33. doi: 10.1186/1471-230X-13-33.
The aim was to investigate the reinfection rate of H. pylori during a follow-up period of 12 months in adults who had undergone eradication therapy.
One hundred-twenty patients; 116 with gastritis, 3 with duodenal ulcer and 1 gastric ulcer, were studied. Their mean age was 41±13 years (range 18-77) and male: female ratio of 2:1. H. pylori were cultured and antibiotic sensitivity was determined by Epsilometer test (E-test) for clarithromycin (CLR) and amoxicillin (AMX). Primers of urease C gene of H. pylori and Sau-3 and Hha I restriction enzymes were used for polymerase chain reaction-restriction fragment length polymorphism analysis (PCR-RFLP). 14C urea breath test (14C-UBT) was performed 4 weeks after the eradication therapy. The successfully treated patients were observed for 12 months with 14C-UBT to assess H. pylori status. If 14C-UBT was negative, it was repeated after every 12 weeks. If 14C-UBT was positive, endoscopy was repeated with biopsies.
The eradication therapy was successful in 102(85%) patients. Out of forty-seven H. pylori isolates cultured, clarithromycin sensitivity was present in 30(64%) and amoxicillin in 45(98%), respectively. Follow-up 14C-urea breath tests of all 102 patients who eradicated H. pylori remained negative up to 9 months. However, in 6 patients, the 14C-UBT confirmed recurrence at 12 months. The recurrence rate was 6%.
A low rate of recurrence of H. pylori infection was found in patients with dyspeptic symptoms. H. pylori isolates demonstrated a high invitro clarithromycin resistance.
本研究旨在调查在根除治疗后 12 个月的随访期间,成年人中幽门螺杆菌的再感染率。
共研究了 120 例患者;其中 116 例为胃炎,3 例为十二指肠溃疡,1 例为胃溃疡。他们的平均年龄为 41±13 岁(范围 18-77),男女比例为 2:1。培养幽门螺杆菌并通过 Epsilometer 试验(E 试验)测定克拉霉素(CLR)和阿莫西林(AMX)的药敏性。使用幽门螺杆菌脲酶 C 基因的引物、Sau-3 和 Hha I 限制性内切酶进行聚合酶链反应-限制性片段长度多态性分析(PCR-RFLP)。根除治疗后 4 周进行 14C 尿素呼气试验(14C-UBT)。成功治疗的患者接受 14C-UBT 观察 12 个月,以评估幽门螺杆菌状态。如果 14C-UBT 为阴性,则每 12 周重复一次。如果 14C-UBT 为阳性,则重复内镜检查并活检。
102 例(85%)患者的根除治疗成功。在培养的 47 株幽门螺杆菌分离株中,克拉霉素的敏感性分别为 30 株(64%)和 45 株(98%)。所有根除幽门螺杆菌的 102 例患者的 14C-UBT 随访至 9 个月均为阴性。然而,在 6 例患者中,14C-UBT 在 12 个月时证实复发。复发率为 6%。
在有消化不良症状的患者中,发现幽门螺杆菌感染的复发率较低。幽门螺杆菌分离株表现出体外克拉霉素耐药率高。